induced tubulointerstitial lesions in children with MCNS who Risk factors for cyclosporine-induced tubulointerstitial lesions had been treated with long-term moderate-dose CsA. in children with minimal change nephrotic syndrome.
The administration of cyclosporine (CsA) years in children with steroid-dependent NS was found
Results. Thirteen patients had CsA-induced tubulointerstito be effective for preventing relapses and decreasing tial lesions and 24 patients had none. Among clinical and labosteroid toxicity. However, repeat renal biopsies carried ratory factors, the duration of CsA treatment (P ϭ 0.003) and out at the end of CsA treatment showed chronic CsA the duration of heavy proteinuria during CsA treatment (P ϭ nephrotoxicity in half of these patients [7, 8] . We also 0.024) were related to the development of CsA-induced tubulofound that in children with idiopathic NS, CAA was interstitial lesions as determined by the univariate analyses. Indeed, CsA-induced tubulointerstitial lesions were found in improved by discontinuation of CsA, but tubulointersti-2 of 18 (11%) patients who had been treated with CsA for less tial lesions did not regress with drug discontinuation than 24 months, but in 11 of 19 patients (58%) who had been [9, 10] . Thus, prevention of the development of CsAtreated for more than 24 months (P ϭ 0.005). They were also induced tubulointerstitial lesions is the most important found in 4 of 23 patients (17%) who had heavy proteinuria issue in CsA treatment for children with idiopathic NS.
for less than 30 days during CsA treatment, but in 9 of 14 patients (64%) who had heavy proteinuria for more than 30
The factors responsible for the development of CsA- The values are expressed as mean Ϯ SE. For univariate analyses, we used the Mann-Whitney U test to compare bulointerstitial lesions while all post-CsA biopsies showed MCNS. The mean age at the onset of NS was 5.2 Ϯ 0.6 unpaired two-group means. The Fisher's exact test was used to evaluate the association between categorical variyears (range 1 to 13). The mean age at the start of CsA therapy was 7.9 Ϯ 0.8 years (range 2 to 16).
ables. For multivariate analyses, the forward, stepwise logistic-regression model was used to identify the risk The definitions and criteria for NS, remission, relapse, steroid-dependency, and steroid-resistance were those factors. The differences were evaluated using Stat-View J-5.0 software (Abacus Concepts Inc., Berkeley, CA, used by the International Study of Kidney Disease in Children [11, 12] . Heavy proteinuria was defined as 2ϩ USA), and those with P Ͻ 0.05 were considered significant. or more by Albustix in morning spot urine.
CsA treatment RESULTS

In patients with steroid-dependent NS, after they had
Thirteen post-CsA biopsy specimens showed characattained remission with prednisolone therapy, CsA (Santeristic striped interstitial fibrosis, and they were thus dimmune oral solution, CyA; Novartis Pharma K.K., diagnosed as having CsA-induced tubulointerstitial leTokyo, Japan) treatment was started at a dose of 100 to sions. In contrast, 24 post-CsA specimens did not show 150 mg/m 2 per day (ϳ3 mg/kg body weight) in two dithe lesions. vided doses. In patients with steroid-resistant NS, CsA
To identify the risk factors for the development of treatment was used to achieve remission. The dose of CsA-induced tubulointerstitial lesions, the following cliniCsA was adjusted to a target blood trough level of 100 cal and laboratory data were examined: sex ratio, initial ng/mL, as measured by monoclonal antibody fluoressteroid responsiveness, initial biopsy findings, age at oncence polarization immunoassay. CsA was administered set of NS, duration between the onset and the start of for at least 18 months. No medicine that might have CsA treatment, age at the start of CsA treatment, age contributed to CsA nephrotoxicity was given during the at the post-CsA biopsy, cyclophosphamide treatment beCsA treatment period.
fore CsA, duration of CsA treatment, number of NS Steroid therapy for relapses of NS relapses during CsA treatment per year, duration of heavy proteinuria during CsA treatment, serum creatiFor steroid therapy, only prednisolone was used. Renine at the start and the end of CsA treatment, urinary lapses of NS during CsA treatment and after CsA discon-␤2-microglobulin at the start and the end of CsA treattinuation were treated with 2 mg/kg per day prednisolone ment, maximum increase of serum creatinine during CsA given in three divided doses (maximum dose 80 mg) for treatment, mean CsA trough level, and mean blood presthe first four weeks. This was followed by alternate-day sure during CsA treatment (Table 1 ). prednisolone at 2 mg/kg, given as a single dose in the Among those criteria, both the duration of CsA treatmorning of every other day for two weeks, after which ment (37.9 Ϯ 5.1 vs. 26.1 Ϯ 1.7 months, P ϭ 0.003) and the dose was decreased by 0.5 mg/kg every two weeks the duration of heavy proteinuria during CsA treatment (for a total of 12 weeks).
(59.0 Ϯ 13.7 vs. 25.7 Ϯ 9.5 days, P ϭ 0.024) were related Histological evaluation to the development of CsA-induced tubulointerstitial lesions by the univariate analysis. Indeed, CsA-induced For each case, two to four serial sections were pretubulointerstitial lesions were found in 2 of 18 (11%) pared by staining with periodic acid-Schiff (PAS) and patients who had been treated with CsA for less than Masson's trichrome. An investigator who was blinded 24 months, but in 11 of 19 patients (58%) who had been to treatment status reviewed the renal biopsy specimens.
treated for more than 24 months (P ϭ 0.005). They were The histological diagnosis of idiopathic NS was based also found in 4 of 23 patients (17%) who had heavy on the criteria of the International Study of Kidney Disproteinuria during CsA treatment for less than 30 days, ease in Children [11, 13] . CsA-induced tubulointerstitial but in 9 of 14 patients (64%) who had heavy proteinuria lesions were defined as characteristic striped tubulointerfor more than 30 days (P ϭ 0.006). The rate of CsAstitial lesions (tubular atrophy accompanying interstitial fibrosis) [14] .
induced tubulointerstitial lesions increased as the dura- tion of CsA treatment increased (Table 2) . Also, the rate DISCUSSION of CsA-induced tubulointerstitial lesions increased as Cyclosporine A is a useful new agent for the managethe duration of heavy proteinuria during CsA treatment ment of steroid-dependent NS in children that replaces increased (Table 3) . corticosteroids and alkylating agents. It may be of particAlthough 10 post-CsA biopsy specimens showed mild ular help for patients who experience serious side effects to moderate CAA, the existence of CAA did not correas a result of continuous steroid therapy. CsA is also late with the development of CsA-induced tubulointereffective for the treatment of steroid-resistant NS. As stitial lesions (P ϭ 0.118). discontinuation of CsA treatment often induces frequent The forward, stepwise logistic-regression analysis rerelapses, a longer period of CsA administration is necesvealed that the duration of CsA treatment for more than sary to maintain a long-term remission. However, long-24 months ( 2 ϭ 6.203, P ϭ 0.013) and the duration of term CsA treatment often results in chronic CsA nephroheavy proteinuria for more than 30 days during CsA toxicity, characterized by CAA and tubulointerstitial letreatment ( 2 ϭ 5.871, P ϭ 0.015) were the independent sions, namely striped fibrosis [7, 8] . In our recent studies, and significant risk factors for the development of CsA-CAA was improved by discontinuation of CsA, but tubuinduced tubulointerstitial lesions (Table 4) . Neither the lointerstitial lesions did not regress with drug discontinuduration of CsA treatment for more than 24 months ( 2 ϭ ation in children with idiopathic NS [9, 10] . Therefore, 3.580, P ϭ 0.059) nor the duration of heavy proteinuria it is important to clarify the risk factors for the developduring CsA treatment for more than 30 days ( 2 ϭ 0.282, ment of CsA-induced tubulointerstitial lesions in order P ϭ 0.595) was the risk factor for the development of to prevent it. Our current study shows that the duration of CsA CAA by the logistic-regression analysis. treatment and the duration of heavy proteinuria during 24 months. If patients relapse, they are treated with steroids for 6 to 12 months, then again with CsA for 1 to CsA treatment are risk factors for the development of CsA-induced tubulointerstitial lesions in children with 2 years, to minimize the toxicity of prolonged administration of CsA [17] . It is notable that in our study the rate of MCNS who had been treated with long-term moderatedose CsA. The rate of CsA-induced tubulointerstitial CsA-induced tubulointerstitial lesions was significantly higher in patients who had been treated with CsA for lesions increased as the duration of CsA treatment increased and the rate of CsA-induced tubulointerstitial more than 24 months than in patients who had been treated with CsA for less than 24 months (58% vs. 11%, lesions increased as the duration of heavy proteinuria during CsA treatment increased, supporting our conclu-P ϭ 0.005). Moreover, the forward, stepwise logisticregression analysis revealed that the duration of CsA sions that the two risk factors are related to the development of CsA-induced tubulointerstitial lesions. Howtreatment for more than 24 months was a significant risk factor for the development of CsA-induced tubulointerever, previous studies have reported that the incidence of chronic CsA nephrotoxicity including CsA-induced stitial lesions ( 2 ϭ 6.203, P ϭ 0.013). These data strongly support Ponticelli and Passerini's treatment strategy for tubulointerstitial lesions was not related to the duration of treatment [14] [15] [16] .
patients with steroid-dependent NS. The present study also demonstrates that long-term Feutren and Mihatch analyzed data from renal biopsies from 192 patients (129 adults and 63 children) who heavy proteinuria during CsA treatment is a significant risk factor for the development of CsA-induced tubulohad been treated with CsA for insulin-dependent diabetes mellitus, uveitis, psoriasis, Sjö gren's syndrome, or interstitial lesions. The longer periods of heavy proteinuria during CsA treatment were due mostly to sterpolychondritis. They found that a larger initial dose of CsA, a larger maximal increase in serum creatinine, and oid-resistant NS or to frequent relapses in spite of CsA treatment, although neither the steroid resistance nor older age were the risk factors for the development of chronic CsA nephrotoxicity [14] . However, the mean the number of relapses was the significant risk factor for the development of CsA-induced tubulointerstitial initial dose of CsA in their study (8.2 mg/kg body wt/ day) was much higher than that in our study (ϳ3 mg/kg lesions. The long-term heavy proteinuria per se might have induced the development of CsA-induced tubuloinbody wt/day). The mean duration of CsA treatment in their study (17.7 months) was much shorter than that in terstitial lesions. However, the results of our previous study regarding the histological changes after CsA disour study (30.3 months). Therefore, their study might have overlooked the significance of the duration of CsA continuation showed that the tubulointerstitial lesions did not deteriorate after CsA discontinuation although treatment as a risk factor for the development of CsAinduced tubulointerstitial lesions. Alternatively, the diflong-term proteinuria due to frequent relapses had been present over the period between CsA discontinuation ference in diseases between their study and our study may account for the discrepancy. and the repeat renal biopsies [10] . Moreover, it has been reported in rats that long-term (6 months) massive proHabib and Niaudet reported that there was no correlation between chronic CsA nephropathy and the duration teinuria induced by multiple injections of anti-rat slit diaphragm monoclonal antibody results in tubular epiof CsA treatment in children with idiopathic nephrotic syndrome [15, 16] . However, they also found that CsAthelial cell injury and cell infiltration but not interstitial fibrosis [18] . Collectively, these findings suggest that CsA induced tubulointerstitial lesions progressed with time in patients who underwent serial post-treatment renal and long-term proteinuria can synergistically induce tubulointerstitial lesions by means of unknown mechabiopsies [16] , which suggests that our data are consistent with theirs. Alternatively, the discrepancy between their nism(s). It is of note that the existence of CAA is not a signifiresults and ours may be explained by the fact that the target blood trough level in their study (100 to 200 ng/ cant risk factor for the development of CsA-induced tubulointerstitial lesions. Neither the duration of CsA mL) was higher than that in ours (100 ng/mL).
Ponticelli and Passerini reported that, in patients with treatment for more than 24 months ( 2 ϭ 3.580, P ϭ 0.059) nor the duration of heavy proteinuria during CsA steroid-dependent NS, CsA should be discontinued after
